Back

GoBroad Healthcare Group Enters Strategic Partnership with Belarus National Academy of Sciences and Minsk Oncology Center

2026-5-19

On May 19, the National Academy of Sciences of Belarus, Minsk City Clinical Oncology Center, and GoBroad Healthcare Group (GHG) officially signed a strategic cooperation agreement. The cooperation was facilitated and supported by the Ministry of Foreign Affairs of Belarus and relevant international cooperation authorities, and was covered by Belarusian national media.

At the signing ceremony, the agreement was signed by Vitaly Zalessky (Виталий Залесский), First Deputy Chairman of the Presidium of the National Academy of Sciences of Belarus; Viktor Kondratovich (Виктор Кондратович), Chief Physician of Minsk City Clinical Oncology Center; and Yvonne Gao, Vice President of GoBroad Healthcare Group, on behalf of the three parties respectively. Vitaly Zalessky (Виталий Залесский) stated at the ceremony that the signing of the agreement opens new opportunities for the development of medicine and science, while laying a solid foundation for long-term, practical, and fruitful cooperation among the three parties.

Under the agreement, the three parties will carry out in-depth exchanges in the field of modern medical technologies, focusing on the sharing of advanced experience, technology research and development, clinical application, and promotion. Moving forward, the parties will also jointly advance scientific, clinical, and educational initiatives, and promote academic exchange and international collaboration through forums, roundtable discussions, thematic seminars, and other academic activities.

The signing of this strategic cooperation agreement marks an important step for GoBroad Healthcare Group in advancing international medical exchange and global scientific collaboration. Looking ahead, GoBroad will continue to work with international medical and research institutions to promote high-quality medical technology exchange, support clinical research and the translation of innovative outcomes, and bring new treatment options and hope to more patients.

Related Articles